Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride

被引：0
|
作者：
Jens Teichert
Frank Baumann
Qi Chao
Craig Franklin
Brandy Bailey
Lothar Hennig
Karel Caca
Konrad Schoppmeyer
Ulrich Patzak
Rainer Preiss
机构：
[1] Universität Leipzig,Institut für Klinische Pharmakologie
[2] Salmedix Inc.,Institut für Organische Chemie
[3] Universität Leipzig,Medizinische Klinik und Poliklinik II
[4] Universitätsklinikum Leipzig AöR,undefined
[5] Astellas Pharma GmbH,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 59卷
关键词：
Bendamustine; Metabolism; Cytochrome P450; Cytotoxic activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：759 / 770
页数：11
相关论文
共 50 条
  • [1] Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride
    Teichert, Jens
    Baumann, Frank
    Chao, Qi
    Franklin, Craig
    Bailey, Brandy
    Hennig, Lothar
    Caca, Karel
    Schoppmeyer, Konrad
    Patzak, Ulrich
    Preiss, Rainer
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (06) : 759 - 770
  • [2] Bendamustine phase I metabolism in human beings
    Teichert, J.
    Patzak, U.
    Chao, Q.
    Franklin, C.
    Bailey, B.
    Schoppmeyer, K.
    Caca, K.
    Preiss, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 378 - 378
  • [3] Phase I Clinical Trial of Bendamustine and Bevacizumab for Patients With Advanced Cancer
    Tsimberidou, Apostolia M.
    Adamopoulos, Alexandra M.
    Ye, Yang
    Piha-Paul, Sarina
    Janku, Filip
    Fu, Siqing
    Hong, David
    Falchook, Gerald S.
    Naing, Aung
    Wheler, Jennifer
    Fortier, Adoneca
    Kurzrock, Razelle
    Hess, Kenneth R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (02): : 194 - 203
  • [4] Determination and Characterization of Two Degradant Impurities in Bendamustine Hydrochloride Drug Product
    Chen, Wenhua
    Zou, Limin
    Zhang, Fei
    Xu, Xiangyang
    Zhang, Liandi
    Liao, Mingyi
    Li, Xiaoqiang
    Ding, Li
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2015, 53 (10) : 1673 - 1679
  • [5] A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors
    Rasschaert, Marika
    Schrijvers, Dirk
    Van den Brande, Jan
    Dyck, Joke
    Bosmans, Johan
    Merkle, Karlheinz
    Vermorken, Jan B.
    ANTI-CANCER DRUGS, 2007, 18 (05) : 587 - 595
  • [6] Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study
    Toshio Shimizu
    Kazuhiko Nakagawa
    Hidetoshi Hayashi
    Tsutomu Iwasa
    Hisato Kawakami
    Satomi Watanabe
    Noboru Yamamoto
    Kan Yonemori
    Takafumi Koyama
    Jun Sato
    Kenji Tamura
    Keiichi Kikuchi
    Kenichiro Akaike
    Shiho Takeda
    Masayuki Takeda
    Investigational New Drugs, 2023, 41 : 1 - 12
  • [7] Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study
    Shimizu, Toshio
    Nakagawa, Kazuhiko
    Hayashi, Hidetoshi
    Iwasa, Tsutomu
    Kawakami, Hisato
    Watanabe, Satomi
    Yamamoto, Noboru
    Yonemori, Kan
    Koyama, Takafumi
    Sato, Jun
    Tamura, Kenji
    Kikuchi, Keiichi
    Akaike, Kenichiro
    Takeda, Shiho
    Takeda, Masayuki
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (01) : 1 - 12
  • [8] A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL
    Jain, Nitin
    Balakrishnan, Kumudha
    Ferrajoli, Alessandra
    O'Brien, Susan M.
    Burger, Jan A.
    Kadia, Tapan M.
    Cortes, Jorge E.
    Ayres, Mary L.
    Tambaro, Francesco Paolo
    Keating, Michael J.
    Gandhi, Varsha
    Wierda, William G.
    ONCOTARGET, 2017, 8 (13) : 22104 - 22112
  • [9] A Phase I/II Trial of Fludarabine, Bendamustine, and Rituximab (FBR) Chemoimmunotherapy for Previously Treated Patients with CLL
    Wierda, William G.
    Balakrishnan, Kumudha
    Ferrajoli, Alessandra
    Kadie, Tapan
    Cortes, Jorge E.
    O'Brien, Susan
    Burger, Jan A.
    Tambaro, Francesco Paolo
    Jalayer, Annette
    Lemer, Susan
    Keating, Michael J.
    Gandhi, Varsha
    BLOOD, 2011, 118 (21) : 1667 - 1667
  • [10] Synthesis and characterization of some new phase II metabolites of the alkylator bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinoma
    Teichert, J
    Sohr, R
    Baumann, F
    Hennig, L
    Merkle, K
    Caca, K
    Preiss, R
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (07) : 984 - 992
12345